27503926|t|SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress - Inducing Agents
27503926|a|SIRT2 is a protein deacetylase with tumor suppressor activity in breast and liver tumors where it is mutated; however, the critical substrates mediating its antitumor activity are not fully defined. Here we demonstrate that SIRT2 binds, deacetylates, and inhibits the peroxidase activity of the antioxidant protein peroxiredoxin (Prdx-1) in breast cancer cells. Ectopic overexpression of SIRT2, but not its catalytically dead mutant, increased intracellular levels of reactive oxygen species (ROS) induced by hydrogen peroxide, which led to increased levels of an overoxidized and multimeric form of Prdx-1 with activity as a molecular chaperone. Elevated levels of SIRT2 sensitized breast cancer cells to intracellular DNA damage and cell death induced by oxidative stress, as associated with increased levels of nuclear FOXO3A and the proapoptotic BIM protein. In addition, elevated levels of SIRT2 sensitized breast cancer cells to arsenic trioxide, an approved therapeutic agent, along with other intracellular ROS - inducing agents. Conversely, antisense RNA - mediated attenuation of SIRT2 reversed ROS - induced toxicity as demonstrated in a zebrafish embryo model system. Collectively, our findings suggest that the tumor suppressor activity of SIRT2 requires its ability to restrict the antioxidant activity of Prdx-1, thereby sensitizing breast cancer cells to ROS - induced DNA damage and cell cytotoxicity. Cancer Res; 76(18); 5467-78. Â©2016 AACR.
27503926	0	5	SIRT2	T116,T126	C2720168
27503926	6	18	Deacetylates	T044	C2246982
27503926	23	55	Inhibits the Peroxidase Activity	T044	C3893923
27503926	59	74	Peroxiredoxin-1	T116,T126	C0672553
27503926	78	107	Sensitize Breast Cancer Cells	T025	C1512505
27503926	111	125	Oxidant Stress	T049	C0242606
27503926	128	136	Inducing	T169	C0205263
27503926	144	149	SIRT2	T116,T126	C2720168
27503926	155	174	protein deacetylase	T044	C2246982
27503926	180	205	tumor suppressor activity	T043	C1325410
27503926	209	215	breast	T191	C0006142
27503926	220	232	liver tumors	T191	C0345904
27503926	245	252	mutated	T049	C1705285
27503926	276	286	substrates	T167	C3891814
27503926	301	319	antitumor activity	T033	C0243095
27503926	368	373	SIRT2	T116,T126	C2720168
27503926	374	379	binds	T044	C1149286
27503926	381	393	deacetylates	T044	C1511737
27503926	399	431	inhibits the peroxidase activity	T044	C3893923
27503926	439	472	antioxidant protein peroxiredoxin	T116,T126	C0672553
27503926	474	480	Prdx-1	T116,T126	C0672553
27503926	485	504	breast cancer cells	T025	C1512505
27503926	506	513	Ectopic	T082	C0574895
27503926	514	528	overexpression	T045	C0017262
27503926	532	537	SIRT2	T116,T126	C2720168
27503926	551	576	catalytically dead mutant	T049	C0596988
27503926	578	587	increased	T081	C0205217
27503926	588	608	intracellular levels	T082	C0178719
27503926	612	635	reactive oxygen species	T123,T196	C0162772
27503926	637	640	ROS	T123,T196	C0162772
27503926	642	671	induced by hydrogen peroxide,	T121,T130,T197	C0020281
27503926	685	694	increased	T081	C0205217
27503926	695	701	levels	T080	C0441889
27503926	708	750	overoxidized and multimeric form of Prdx-1	T116,T126	C0672553
27503926	756	789	activity as a molecular chaperone	T116,T123	C0243041
27503926	791	799	Elevated	T080	C3163633
27503926	800	806	levels	T080	C0441889
27503926	810	815	SIRT2	T028	C1420071
27503926	816	846	sensitized breast cancer cells	T025	C1512505
27503926	850	874	intracellular DNA damage	T049	C0012860
27503926	879	917	cell death induced by oxidative stress	T043	C3894015
27503926	938	947	increased	T081	C0205217
27503926	948	954	levels	T080	C0441889
27503926	958	972	nuclear FOXO3A	T116,T123	C1333633
27503926	981	1005	proapoptotic BIM protein	T116,T123	C4282114
27503926	1020	1028	elevated	T080	C3163633
27503926	1029	1035	levels	T080	C0441889
27503926	1039	1044	SIRT2	T116,T126	C2720168
27503926	1045	1075	sensitized breast cancer cells	T025	C1512505
27503926	1079	1095	arsenic trioxide	T121,T131,T197	C0052416
27503926	1109	1126	therapeutic agent	T073	C0304231
27503926	1145	1162	intracellular ROS	T123,T196	C0162772
27503926	1165	1180	inducing agents	T121	C1254351
27503926	1194	1207	antisense RNA	T114,T123,T130	C0080124
27503926	1210	1230	mediated attenuation	T052	C0599946
27503926	1234	1239	SIRT2	T116,T126	C2720168
27503926	1240	1248	reversed	T169	C1555029
27503926	1249	1252	ROS	T123,T196	C0162772
27503926	1255	1271	induced toxicity	T037	C1516457
27503926	1293	1302	zebrafish	T013	C0043457
27503926	1303	1322	embryo model system	T018	C0013935
27503926	1368	1393	tumor suppressor activity	T043	C1325410
27503926	1397	1402	SIRT2	T116,T126	C2720168
27503926	1427	1435	restrict	T169	C0443288
27503926	1440	1460	antioxidant activity	T044	C1148564
27503926	1464	1470	Prdx-1	T116,T126	C0672553
27503926	1480	1511	sensitizing breast cancer cells	T025	C1512505
27503926	1515	1518	ROS	T123,T196	C0162772
27503926	1521	1539	induced DNA damage	T049	C0012860
27503926	1544	1561	cell cytotoxicity	T049	C0596402